pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 8·1 min read
save

The biotechs wear Prada

Was Naomi Osaka's Met Gala outfit inspired by Gilead's logo? Janelle Monáe's by Insilico's? Probably not — and yet.

May 8, 2026·read at STAT ↗

Biotech The biotechs wear Prada The Meta Gala outfits seen as biopharma logos? Why not Manage alerts for this article Email this article Share this article By Elaine ChenMay 8, 2026 National Biotech Reporter Elaine Chen[email protected]Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.

This is an excerpt from The Readout, STAT’s newsletter about biotech. Sign up to get it in your inbox every weekday. Longtime subscribers of STAT’s newsletter The Readout may recall that when early May rolls around, we have an annual tradition: Met Gala outfits as biopharma logos.

(See the previous years’ editions here and here.)Advertisement This year’s Met Gala dress code was “Fashion is Art.” I do believe that all fashion is art, and I’m sure the marketing teams at biotech companies would argue that corporate logos are art, too. Credit goes to my colleagues Brittany Trang and Allison DeAngelis for finding these pairings! biotechnology, Pharmaceuticals Submit a correction requestReprints Elaine Chen National Biotech Reporter Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.

You can reach Elaine on Signal at elaineywchen.70. Newsletter Your morning rundown of the science, politics, and money driving biotech today Recommended The Readout May 8, 2026 STAT Plus: The biotech news you need to read today The Readout May 7, 2026 STAT Plus: FDA revisits a rare cancer treatment it rejected a few months ago Advertisement Biotech May 7, 2026 STAT Plus: FDA to reconsider treatment for rare cancer after its surprise rejection Biotech May 7, 2026 STAT Plus: Next-gen Duchenne drug from Entrada disappoints Adam's Biotech Scorecard May 7, 2026 STAT Plus: Color me skeptical: Drinking gold is not an ALS cure Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
299 words · retrieved May 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.2GILEAD
topics
Oncology2Rare Disease2ALSDuchenne Muscular DystrophyRecall

related stories

  • 17h agoCapricor, Replimune illustrate why FDA must listen to rare disease specialistsBioSpace
  • Aug 54 potential biotech M&A targets, plus a pretty sure bet from J&JBioSpace
  • Jul 30New funding, new jobs: 4 biotechs hiring after series B raisesBioSpace
  • May 8STAT+: The biotech news you need to read todaySTAT
  • May 7STAT+: FDA revisits a rare cancer treatment it rejected a few months agoSTAT